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OBJECTIVES The goal of this study was to test the hypothesis that exercise training reduces resting
sympathetic neural activation in patients with chronic advanced heart failure.
BACKGROUND Exercise training in heart failure has been shown to be beneficial, but its mechanisms of
benefit remain unknown.
METHODS Sixteen New York Heart Association class II to III heart failure patients, age 35 to 60 years,
ejection fraction 40% were divided into two groups: 1) exercise-trained (n  7), and 2)
sedentary control (n  9). A normal control exercise-trained group was also studied (n  8).
The four-month supervised exercise training program consisted of three 60 min exercise
sessions per week, at heart rate levels that corresponded up to 10% below the respiratory
compensation point. Muscle sympathetic nerve activity (MSNA) was recorded directly from
peroneal nerve using the technique of microneurography. Forearm blood flow was measured
by venous plethysmography.
RESULTS Baseline MSNA was greater in heart failure patients compared with normal controls; MSNA
was uniformly decreased after exercise training in heart failure patients (60  3 vs. 38  3
bursts/100 heart beats), and the mean difference in the change was significantly (p  0.05)
greater than the mean difference in the change in sedentary heart failure or trained normal
controls. In fact, resting MSNA in trained heart failure patients was no longer significantly
greater than in trained normal controls. In heart failure patients, peak VO2 and forearm blood
flow, but not left ventricular ejection fraction, increased after training.
CONCLUSIONS These findings demonstrate that exercise training in heart failure patients results in dramatic
reductions in directly recorded resting sympathetic nerve activity. In fact, MSNA was no
longer greater than in trained, healthy controls. (J Am Coll Cardiol 2003;42:854–60)
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Neurohumoral activation, including activation of the sym-
pathetic nervous system, typifies advanced heart failure
(HF), and patients with the greatest sympathetic activation
have the poorest survival (1,2). Sympathetic excitation
activates the renin-angiotensin system, increases peripheral
vasoconstriction, and lowers the ventricular fibrillation
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threshold, thereby directly contributing to end-organ hypo-
perfusion and sudden death risk (3). Virtually every phar-
macologic therapy proven to increase survival in chronic
HF, and, thus, mandated in its treatment, interrupts this
neural humoral activation (4–7). Exercise training is being
increasingly prescribed in HF, and has been found to
improve functional class, exercise ability, and quality of life
(8–10). Its mechanism of benefit is unknown. Exercise
training partially reverses the skeletal myopathy of HF, and
improves peripheral blood flow (11). The effects of exercise
on autonomic function in HF have been studied using
plasma norepinephrine levels, heart rate (HR) variability,
and the whole body norepinephrine spillover technique
(12–15), with conflicting results.
Gordon et al. (12) reported that eight weeks of two-
legged knee extensor exercise improved exercise ability and
quality of life in chronic HF patients, but did not reduce
resting plasma norepinephrine levels. Other investigators
found that eight weeks of training improved indexes of HR
variability analyzed in both the time domain and the
frequency domain (13,14). Adamopoulos and colleagues
(15) extended these improvements to the circadian pattern
of HR variability as well. These findings are consistent with
a return of sympathetic-vagal balance after exercise training.
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Using the whole body norepinephrine spillover technique,
Coats et al. (14) reported a reduction in sympathetic
activation after eight weeks of bicycle training. As these
investigators noted, however, the norepinephrine spillover
technique does not distinguish between augmented central
sympathetic outflow and altered norepinephrine dynamics
at the nerve terminal. In addition to these potential benefits
of exercise training on restoring resting autonomic balance
in HF, it is possible that the exaggerated sympathetic
excitation (16) and regional vasoconstriction (17) during
exercise in HF is reversed by exercise training, further
improving exercise ability, quality of life, and even mortality.
The purpose of our study was to use direct recordings of
muscle sympathetic nerve activity (MSNA) to test the
hypothesis that exercise training reduces resting sympathetic
neural activation in patients with chronic advanced HF.
METHODS
Study population. All subjects gave written informed con-
sent for this study, which was approved by the Human
Subject Protection Committee of the Heart Institute (In-
Cor) and Clinical Hospital, University of Sa˜o Paulo Med-
ical School. Consecutive out-patients meeting the following
inclusion/exclusion criteria were offered participation in the
study: 1) age between 35 to 60 years, 2) no recent (3
months) myocardial infarction or unstable angina, 3) stable
HF duration 3 months, 4) no muscle skeletal abnormality
(e.g., arthritis) prohibiting participation in an exercise pro-
gram, 5) New York Heart Association (NYHA) class II to
III HF, and 6) ejection fraction 40%.
Normal healthy volunteers between the ages of 35 to 60
years had normal history and physical examinations, were
not involved in exercise training for six months, and were
not taking any medications.
Study protocol. Patients with HF were randomized to the
training group or sedentary control group. All normal
control subjects were enrolled in the exercise training group.
Resting MSNA was recorded in the fasting state in patients
and normal controls within three weeks of initiating the
exercise or sedentary programs, and within one week of
concluding the exercise or sedentary programs. Subjects
were positioned for microneurography, and a satisfactory
nerve recording site from the peroneal nerve was obtained
pre- and post-intervention. Blood pressure, forearm blood
flow (FBF), and HR were measured noninvasively. After a
15-min rest period, 10 min of resting MSNA and HR were
recorded; FBF and blood pressure were recorded for 2 min.
Exercise training program. The training program was
based on several published protocols that have demonstrated
a conditioning effect (8,13,14). Subjects underwent exercise
training under supervision at the Heart Institute. The
four-month training program consisted of three 60-min
exercise sessions/week. Each exercise session consisted of 5
min stretching exercises, 25 min of cycling on an ergometer
bicycle in the first month and up to 40 min in the last three
months, 10 min of local strengthening exercises (sit-ups,
push-ups, and pull-ups), 5 min of cool down with stretching
exercises. The exercise intensity was established by HR
levels that corresponded to anaerobic threshold up to 10%
below the respiratory compensation point obtained in the
cardiopulmonary exercise test. In one patient the respiratory
compensation point was not detectable. In that patient, the
exercise training was determined at the anaerobic threshold.
When a training effect was observed, as indicated by a
decrease by 8% to 10% in HR during exercise, the bicycle
work rate was increased by 0.25 or 0.5 kpm to return to the
target HR levels. Aerobic exercise training duration in-
creased progressively so that all patients could perform 40
min of bicycle exercise at the established intensity. Compli-
ance was assessed as percentage of exercise sessions
attended.
Sedentary program. Patients were instructed to avoid any
regular exercise program or any nonsupervised exercise
program. The patients were asked about exercise each visit
to the hospital (approximately every three weeks).
Resting MSNA. Resting MSNA was recorded directly
from the peroneal nerve using the technique of microneu-
rography (18,19). Multiunit post-ganglionic muscle sympa-
thetic nerve recordings were made using a tungsten micro-
electrode. Signals were amplified by a factor of 50,000 to
100,000 and bandpassed filtered (700 to 2,000 Hz). Nerve
activity was rectified and integrated (time constant 0.1 s) to
obtain a mean voltage display of sympathetic nerve activity
that was recorded on paper. All recordings of MSNA met
previously established and described criteria. Muscle sym-
pathetic bursts were identified by visual inspection by a
single investigator (C.E.N.) blinded to the study protocol,
and were expressed as burst frequency (bursts per min), and
bursts per 100 heart beats. The reproducibility of MSNA
measured at different time intervals in the same individual
expressed as bursts/min is r  0.88, and expressed as
bursts/100 heart beats is r  0.91 (20).
FBF. Forearm blood flow was measured by venous occlu-
sion plethysmography. The nondominant arm was elevated
above heart level to ensure adequate venous drainage. A
mercury-filled silastic tube attached to a low-pressure trans-
ducer was placed around the forearm and connected to a
plethysmography (Hokanson, Bellevue, Washington).
Sphygmomanometer cuffs were placed around the wrist and
upper arm. At 15-s intervals, the upper cuff was inflated
above venous pressure for 7 to 8 s. Forearm blood flow
Abbreviations and Acronyms
FBF  forearm blood flow
FVR  forearm vascular resistance
HF  heart failure
HR  heart rate
MSNA  muscle sympathetic nerve activity
NYHA  New York Heart Association
VO2  oxygen uptake
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(ml/min/100 ml tissue) was determined on the basis of a
minimum of four separate readings. Forearm vascular resis-
tance (FVR) was calculated by dividing mean arterial
pressure by FBF. The reproducibility of FBF measured at
different time intervals in the same individual expressed as
ml/min/100 ml tissue in our laboratory is r  0.93.
Cardiopulmonary exercise testing. Maximal exercise ca-
pacity was determined by means of a maximal progressive
exercise test on an electromagnetically braked cycle ergome-
ter (Medifit 400L, Medical Fitness Equipment, Maarn,
Netherlands), with work rate increments of 15W and 30W
every 3 min at 60 rpm until exhaustion for HF patients and
normal controls, respectively. Oxygen uptake (VO2) and
carbon dioxide production were determined by means of gas
exchange on a breath-by-breath basis in a computerized
system (CAD/Net 2001, Medical Graphics Corporation,
St. Paul, Minnesota). Peak VO2 was defined as the maxi-
mum attained VO2 at the end of the exercise period in
which the subject could no longer maintain the cycle
ergometer velocity at 60 rpm. This method is considered the
gold standard for assessing patients’ exercise capacity (21).
Anaerobic threshold was determined to occur at the break-
point between the increase in the carbon dioxide output and
VO2 (V-slope) (22) or the point at which the ventilatory
equivalent for oxygen and end-tidal oxygen partial pressure
curves reached their respective minimum values and began
to rise (23). Respiratory compensation was determined to
occur at the point at which ventilatory equivalent for carbon
dioxide was lowest before a systematic increase and when
end-tidal carbon dioxide partial pressure reaches a maxi-
mum and begins to decrease (24). The reproducibility of the
peak VO2 measured at a different time interval in the same
individual expressed as ml/kg/min in our laboratory is r 
0.95.
Miscellaneous measurements. Arterial pressure was mon-
itored noninvasively. Heart rate was monitored continu-
ously through lead II of the electrocardiogram. Ejection
fraction was determined from the two-dimensional
echocardiography.
Statistical analysis. The data are presented as mean 
SEM. Statistical analysis was performed using paired Stu-
dent t tests to compare within-group values before and after
intervention, and unpaired Student t tests to make between-
group comparisons. To determine if the mean delta value
(pre/post) was the same in all three groups, one-way analysis
of variance was used. In the case of significance, Scheffe´’s
post-hoc comparison was used to determine differences
between groups. A p value of  0.05 was considered
statistically significant.
RESULTS
Sixteen advanced HF patients and eight healthy volunteers
were enrolled in this study. Heart failure patients were older
than healthy volunteers (mean age, 53  9 vs. 46  5 years,
p  0.03). Characteristics of patients and controls are
displayed in Table 1. There were no differences between HF
patients randomized to the exercise or sedentary groups in
Table 1. Baseline Physiologic Parameters
HF—Exercise
N  7
HF—Sedentary
N  9
Normal Controls
N  8
Gender (M/F) 5/2 6/3 5/3
Weight (kg) 64.6  4.8 61.4  4.3 67.3  3.6
HF etiology
Coronary artery disease 1 0
Idiopathic 5 5
Chagas 1 4
Medications
ACEI 7 9
Digoxin 7 9
Furosemide 5 5
Hydrochlorothiazide 2 2
Spironolactone 3 3
Beta-adrenergic blocker 0 0
HF duration (yrs) 3.7  0.3 3.4  1
Peak VO2 (ml/kg/min) 14.8  2 16.6  2 27.5  3*
Heart rate (beats/min) 77  3 79  7 67  3*
MAP (mm Hg) 100  4 98  3 102  3
LVEF (%) 35  3 35  3 73  3*
MSNA (bursts/min) 46  3 44  4 27  3*
(bursts/100 heart beats) 60  3 56  3 41  4*
FBF (ml/min/100 ml tissue) 1.7  0.2 2.1  0.1 2.6  0.2*
FVR (U) 61  4 47  7 40  2*
Values are mean  SD. *Value versus HF patients, p  0.05.
ACEI  angiotensin-converting enzyme inhibitors; FBF  forearm blood flow; FVR  forearm vascular resistance; HF 
heart failure; LVEF  left ventricular ejection fraction; MAP mean arterial pressure; MSNA  muscle sympathetic nerve
activity; VO2  oxygen uptake.
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any of the parameters measured. Normal controls had
higher peak VO2 (p  0.0001), left ventricular ejection
fraction (p  0.0001), and FBF (p  0.03), and lower HR
(p  0.04), MSNA (p  0.001), and FVR (p  0.01) than
HF patients. All HF patients and normal controls com-
pleted the study. There were no adverse events. Medications
were not altered during the study period.
Compliance. Compliance with the exercise program was
excellent, ranging from 85% to 98% of exercise sessions
attended for both HF patients and normal controls.
Impact of exercise or sedentary period on physiologic
parameters. Peak VO2 and FBF significantly increased (p
 0.02 and p  0.004, respectively), and FVR significantly
decreased (p 0.002) after exercise training in patients with
HF (Table 2). Left ventricular ejection fraction did not
change (p  0.388). No parameters changed in the seden-
tary HF group. In trained normal control subjects, peak
VO2 increased (p  0.01).
Examples of resting MSNA before and after exercise
training are shown in Figure 1. Muscle sympathetic nerve
activity as measured by bursts/min or bursts/100 heart beats
was uniformly and dramatically decreased (p 0.006 or p
0.003, respectively) after training compared with baseline in
HF patients (Table 2, Fig. 2) and was no longer greater than
in trained, normal controls. In sedentary HF patients and in
trained, healthy controls, resting MSNA did not change
from baseline (p  0.777 and p  0.525, respectively). The
mean difference in the change (Scheffe´’s post-hoc compar-
isons) in MSNA was significantly greater in trained HF
patients compared with sedentary HF patients (p  0.01).
DISCUSSION
The major new finding in this study is that exercise training
results in dramatic reductions in directly recorded resting
MSNA in chronic HF patients. In fact, we found that the
sympathetic excitation characteristic of HF was reversed by
exercise training, and sympathetic nerve activity levels were
Table 2. Physiologic Parameters Post/Pre-Exercise or Sedentary Period
Pre Post
Mean
Difference
in the Change
Peak VO2 (ml/kg/min)
HF exercise 14.8  2 20.6  3* 5.8  2†
HF sedentary 16.6  2 17.5  2 0.9  1
Normal exercise 27.5  3 33.3  2* 5.8  1†
NYHA functional class
HF exercise 2.6  0.2 1.3  0.3* ()1.3  0.2†
HF sedentary 2.5  0.2 2.3  0.2 ()0.3  0.2
Heart rate (beats/min)
HF exercise 77  3 65  3* ()12  5
HF sedentary 79  7 76  6 ()3  4
Normal exercise 67  3 65  3 ()2  2
MAP (mm Hg)
HF exercise 100  4 93  3 ()7  3
HF sedentary 98  3 99  3 1  4
Normal exercise 102  3 94  3 ()7  2
LVEF (%)
HF exercise 35  3 34  2 2.4  2
HF sedentary 35  3 35  2 ()0.1  2
Normal exercise 73  3 73  3 0  1
FBF (ml/min/100 ml tissue)
HF exercise 1.7  0.2 3.0  0.3* 1.3  0.4†
HF sedentary 2.1  0.1 1.7  0.2 ()0.4  0.3
Normal exercise 2.6  0.2 3.0  0.2 0.4  0.4
FVR (U)
HF exercise 61  4 33  2* ()27  6†
HF sedentary 47  7 60  7 13  7
Normal exercise 40  2 32  2 ()8  3
MSNA (bursts/min)
HF exercise 46  3 24  1* ()21  4†‡
HF sedentary 44  4 43  3 ()1  1
Normal exercise 27  3 26  1 ()2  1
MSNA (bursts/100 heart beats)
HF exercise 60  3 38  3* ()23  3†‡
HF sedentary 56  3 56  2 ()2  2
Normal exercise 41  4 40  3 ()1  2
Values are mean  SD. *Within group comparison, p  0.05; †vs. HF sedentary value (mean difference in the change), p 
0.05; ‡vs. normal exercise value (mean difference in the change), p  0.05.
NYHA  New York Heart Association; other abbreviations as in Table 1.
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no longer different from resting sympathetic nerve activity
levels in trained, healthy controls. Muscle sympathetic nerve
activity did not change after exercise training in normal
controls, consistent with prior reports (25). These findings
have important implications for the role of exercise in the
treatment of HF.
Exercise training in patients with chronic congestive HF
has been shown to improve endothelial function, vasodila-
tion, and muscle blood flow, as well as NYHA functional
class (8–11,26). As anticipated, in our study functional class
was uniformly improved. Most importantly, central sympa-
thetic neural outflow, measured directly using the technique
Figure 1. Sympathetic neurograms. (A) Heart failure patients, exercise group. Pre-training, muscle sympathetic nerve activity (MSNA) is markedly
elevated. Post-exercise training, sympathetic nerve activity levels are reduced. (B) Heart failure patients, sedentary group; MSNA levels are markedly
elevated before and after the sedentary period.
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of microneurography, was found to be markedly reduced
after exercise training. We also found that our exercise
paradigm produced an increase in FBF and decrease in FVR
after exercise training. This increased resting muscle blood
flow may reflect the decline in resting sympathetic activa-
tion, but the underlying mechanisms were not investigated,
and are beyond the scope of this study.
The mechanisms underlying the sympathetic activation
in HF remain unknown. Several hypotheses have been
advanced including baroreceptor dysfunction leading to
attenuation of tonic inhibition of central sympathetic out-
flow (27,28). Alternatively, in the “muscle hypothesis,”
abnormal skeletal metabolism may lead to increased isch-
emic metabolite release, thereby increasing muscle ergore-
ceptor sensitivity and increased central sympathetic outflow
(29). Exercise training in patients with HF has been shown
to improve the skeletal muscle abnormalities of HF, includ-
ing reversal of muscle atrophy, increased mitochondrial
enzyme content, and improved muscle metabolism (11,30).
Although we are unable to identify the exact mechanism of
this sympatholytic effect of exercise, we are confident that it
is not due to a dramatic, or even modest, improvement in
cardiac function because the ejection fraction remained
stable throughout the study.
Study limitations. We recognize many limitations in this
study. Although we found a dramatic reduction in sympa-
thetic nerve activity directed to muscle, it is not feasible to
measure sympathetic activity to other organs such as the
heart or kidneys. Sympathetic activation to heart, kidney,
and MSNA tend to parallel each other in animal models,
and are governed by similar control mechanisms, so it is
likely that exercise decreased sympathetic excitation to these
organs as well. Nonetheless, the clinical relevance of these
findings is without question, because MSNA is the largest
Figure 2. Muscle sympathetic nerve activity (MSNA) pre/post exercise/sedentary periods quantified as bursts/min (A) and bursts/100 heart beats (B).
Post-exercise training MSNA levels compared with pre-training MSNA levels in heart failure (HF) patients are uniformly and markedly reduced and are
no longer higher than normal controls; MSNA remained unchanged in the HF sedentary group and the normal control exercise group.
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contributor to serum norepinephrine levels, and it is the
serum norepinephrine level that has been linked directly to
prognosis in HF (2). In this study we measured resting, not
exercising, MSNA. Although resting sympathetic levels
have clear prognostic importance (2), we do not know from
this study whether exercising MSNA was also reduced after
training, thereby potentially contributing to the improve-
ment in exercise tolerance. The exercise paradigm used in
this study was rigorous; compliance within the general HF
population remains to be assessed. Further studies will be
required to investigate the optimal exercise program to
optimize compliance without sacrificing the beneficial ef-
fects on the autonomic nervous system. Finally, HF patients
in this study were not taking beta-adrenergic blockers.
Azevedo et al. (31) reported that beta-adrenergic drugs do
not alter central sympathetic outflow, so it is unlikely that
the addition of beta-blockers would have an adverse effect,
and, in fact, these therapies may be complementary.
Conclusions. Exercise training dramatically decreases cen-
tral sympathetic nerve outflow measured directly. All phar-
macologic therapies with beneficial effects on the neurohu-
moral system in patients with HF have also been shown to
reduce mortality. Larger studies empowered to test the
effects of exercise on mortality in HF are indicated.
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